Literature DB >> 34543105

Shigella flexneri Diguanylate Cyclases Regulate Virulence.

Ruchi Ojha1, Ashley A Dittmar1, Geoffrey B Severin2, Benjamin J Koestler1.   

Abstract

Shigella flexneri is an intracellular human pathogen that invades colonic cells and causes bloody diarrhea. S. flexneri evolved from commensal Escherichia coli, and genome comparisons reveal that S. flexneri has lost approximately 20% of its genes through the process of pathoadaptation, including a disproportionate number of genes associated with the turnover of the nucleotide-based second messenger cyclic di-GMP (c-di-GMP); however, the remaining c-di-GMP turnover enzymes are highly conserved. c-di-GMP regulates many behavioral changes in other bacteria in response to changing environmental conditions, including biofilm formation, but this signaling system has not been examined in S. flexneri. In this study, we expressed VCA0956, a constitutively active c-di-GMP synthesizing diguanylate cyclase (DGC) from Vibrio cholerae, in S. flexneri to determine if virulence phenotypes were regulated by c-di-GMP. We found that expressing VCA0956 in S. flexneri increased c-di-GMP levels, and this corresponds with increased biofilm formation and reduced acid resistance, host cell invasion, and plaque size. We examined the impact of VCA0956 expression on the S. flexneri transcriptome and found that genes related to acid resistance were repressed, and this corresponded with decreased survival to acid shock. We also found that individual S. flexneri DGC mutants exhibit reduced biofilm formation and reduced host cell invasion and plaque size, as well as increased resistance to acid shock. This study highlights the importance of c-di-GMP signaling in regulating S. flexneri virulence phenotypes. IMPORTANCE The intracellular human pathogen Shigella causes dysentery, resulting in as many as one million deaths per year. Currently, there is no approved vaccine for the prevention of shigellosis, and the incidence of antimicrobial resistance among Shigella species is on the rise. Here, we explored how the widely conserved c-di-GMP bacterial signaling system alters Shigella behaviors associated with pathogenesis. We found that expressing or removing enzymes associated with c-di-GMP synthesis results in changes in Shigella's ability to form biofilms, invade host cells, form lesions in host cell monolayers, and resist acid stress.

Entities:  

Keywords:  Shigella; biofilm; c-di-GMP; cell-cell spread; diguanylate cyclase; intracellular pathogen; invasion

Mesh:

Substances:

Year:  2021        PMID: 34543105      PMCID: PMC8570270          DOI: 10.1128/JB.00242-21

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  109 in total

1.  The glutamate-dependent acid resistance system of Escherichia coli and Shigella flexneri is inhibited in vitro by L-trans-pyrrolidine-2,4-dicarboxylic acid.

Authors:  Scott R Waterman; P L C Small
Journal:  FEMS Microbiol Lett       Date:  2003-07-15       Impact factor: 2.742

2.  Plasmid-associated adherence of Shigella flexneri in a HeLa cell model.

Authors:  T Pál; T L Hale
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

Review 3.  The inside story of Shigella invasion of intestinal epithelial cells.

Authors:  Nathalie Carayol; Guy Tran Van Nhieu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

4.  Quantification of high-specificity cyclic diguanylate signaling.

Authors:  Jonathan P Massie; Evan L Reynolds; Benjamin J Koestler; Jian-Ping Cong; Marco Agostoni; Christopher M Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

5.  Role of the GGDEF regulator PleD in polar development of Caulobacter crescentus.

Authors:  Phillip Aldridge; Ralf Paul; Patrick Goymer; Paul Rainey; Urs Jenal
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

6.  Stimulation of innate immunity by in vivo cyclic di-GMP synthesis using adenovirus.

Authors:  Benjamin J Koestler; Sergey S Seregin; David P W Rastall; Yasser A Aldhamen; Sarah Godbehere; Andrea Amalfitano; Christopher M Waters
Journal:  Clin Vaccine Immunol       Date:  2014-09-17

7.  Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157.

Authors:  Qi Jin; Zhenghong Yuan; Jianguo Xu; Yu Wang; Yan Shen; Weichuan Lu; Jinhua Wang; Hong Liu; Jian Yang; Fan Yang; Xiaobing Zhang; Jiyu Zhang; Guowei Yang; Hongtao Wu; Di Qu; Jie Dong; Lilian Sun; Ying Xue; Ailan Zhao; Yishan Gao; Junping Zhu; Biao Kan; Keyue Ding; Shuxia Chen; Hongsong Cheng; Zhijian Yao; Bingkun He; Runsheng Chen; Dalong Ma; Boqin Qiang; Yumei Wen; Yunde Hou; Jun Yu
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

Review 8.  Escherichia coli acid resistance: tales of an amateur acidophile.

Authors:  John W Foster
Journal:  Nat Rev Microbiol       Date:  2004-11       Impact factor: 60.633

9.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

10.  Enzymatically active and inactive phosphodiesterases and diguanylate cyclases are involved in regulation of Motility or sessility in Escherichia coli CFT073.

Authors:  Rachel R Spurbeck; Rebecca J Tarrien; Harry L T Mobley
Journal:  MBio       Date:  2012-10-09       Impact factor: 7.867

View more
  1 in total

1.  YfiB: An Outer Membrane Protein Involved in the Virulence of Shigella flexneri.

Authors:  Tanuka Sen; Naresh K Verma
Journal:  Microorganisms       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.